Participants include Kevin Outterson, Executive Director of CARB-X.

The Global AMR R&D Hub is pleased to announce a one-day workshop on “Increasing Investments
for AMR R&D”, which will take place on Tuesday May 28 2019 in Geneva, Switzerland. The event
will gather representatives from governments, funders, industry, investors and other stakeholders
interested in the field of antimicrobial resistance.

Antimicrobial resistance (AMR) represents an urgent major global health threat. Currently, there is
an insufficient number of treatments and tools in the AMR research and development (R&D)
pipeline to tackle this issue. Building on ongoing initiatives, increasing investments across the One
Health spectrum is required. In particular, more effort is needed in the animal and plant fields as
well as applicability in low- and middle-income countries (LMIC).

This workshop aims to discuss investments and financing mechanisms for AMR R&D and provide
recommendations for funders and investors on how to address the vital issue of increasing
investments in AMR R&D in a One Health context that also considers applicability in LMIC.

Please click here to learn more.